• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT MITRACLIP SYSTEM STEERABLE GUIDE CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT MITRACLIP SYSTEM STEERABLE GUIDE CATHETER Back to Search Results
Catalog Number SGC0302
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Anemia (1706); Hemorrhage/Bleeding (1888)
Event Date 01/21/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The device was discarded.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
This report is filed due to post-procedure access site bleeding.It was reported that on (b)(6) 2017, the patient had a previous mitral valve procedure.One mitraclip was implanted without reported issues.The mitral regurgitation was reduced from grade 4 to 2.On (b)(6) 2019, a baseline echocardiogram was performed and mitral regurgitation was observed grade 4+.Reportedly, the previously implanted mitraclip remained stable and well seated.There was no tissue or leaflet injury suspected.On (b)(6) 2019, two mitraclips were implanted, without a device issue, reducing the mr to grade 1+.Post-procedure, bleeding from the puncture site was observed along with low hemoglobin.As treatment, one unit of packed red blood cells was provided; manual compression was held for 1 hour and a new compression bandage was applied for 2 hours.Right femoral angiography performed on (b)(6) 2019 showed normal results.The event resolved without sequela.No additional information was provided regarding this issue.
 
Manufacturer Narrative
Internal file number - (b)(4).There was no device malfunction and the device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effect of hemorrhage is listed in the mitraclip system instructions for use is a known possible complication associated with mitraclip procedures.Based on the information reviewed, the reported anemia and hemorrhage appear to be related to procedural conditions, and unrelated to the device since there was no reported device issue/malfunction during the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP SYSTEM STEERABLE GUIDE CATHETER
Type of Device
STEERABLE GUIDE CATHETER
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
MDR Report Key8350510
MDR Text Key136499638
Report Number2024168-2019-01205
Device Sequence Number1
Product Code DRA
Combination Product (y/n)N
PMA/PMN Number
K161985
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,s
Remedial Action Other
Type of Report Initial,Followup
Report Date 03/21/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/03/2019
Device Catalogue NumberSGC0302
Device Lot Number81003U156
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 01/29/2019
Initial Date FDA Received02/19/2019
Supplement Dates Manufacturer Received03/14/2019
Supplement Dates FDA Received03/21/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
3 IMPLANTED MITRACLIPS; 3 IMPLANTED MITRACLIPS
Patient Outcome(s) Required Intervention;
Patient Age89 YR
Patient Weight80
-
-